Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Research and Development In Brief

This article was originally published in The Tan Sheet

Executive Summary

Grain fiber/magnesium lowers diabetes risk: High fiber intake from grains and cereals and high intake of magnesium are associated with a lower risk of type 2 diabetes, according to a study report and meta-analysis published in the May 14 Archives of Internal Medicine. Matthias B. Schulze, Dr.P.H., et al., the German Institute of Human Nutrition, evaluated the diet of 9,702 men and 15,365 women ages 35 to 65 for approximately seven years. The 844 subjects in the study who developed type 2 diabetes were split into five groups according to fiber intake; those who consumed the most fiber had a 27% lower risk of developing diabetes than those who ate the least amount of fiber. A meta-analysis found subjects in the highest cereal fiber group had a 33% lower diabetes risk compared to the low fiber group, and the high magnesium group had a 23% lower diabetes risk than the low magnesium group...

You may also be interested in...



People In Brief

Perrigo promotes in pricing, planning

In Brief

Combe sells most of its OTC brands

Supplement GMP Warning Letters Make Modest Debut In 2010

Finalization of a settlement between the Federal Trade Commission and Rexall Sundown regarding unsupported cellulite treatment claims for the firm's Cellasene dietary supplement hinges upon approval of two related class action settlements pending in California and Florida, according to FTC

Topics

UsernamePublicRestriction

Register

PS100552

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel